Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Cyanotech (CYAN) Competitors

Cyanotech logo

CYAN vs. HAPP, BON, SMFL, CDXC, BGXX, CYCN, TLPH, DWTX, APRE, and NURO

Should you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), Bon Natural Life (BON), Smart for Life (SMFL), ChromaDex (CDXC), Bright Green (BGXX), Cyclerion Therapeutics (CYCN), Talphera (TLPH), Dogwood Therapeutics (DWTX), Aprea Therapeutics (APRE), and NeuroMetrix (NURO).

Cyanotech vs. Its Competitors

Happiness Development Group (NASDAQ:HAPP) and Cyanotech (NASDAQ:CYAN) are both small-cap medicinals & botanicals industry companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Happiness Development GroupN/A N/A N/A
Cyanotech -19.50%-44.71%-19.12%

Happiness Development Group has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, Cyanotech has a beta of -0.11, suggesting that its share price is 111% less volatile than the S&P 500.

15.2% of Happiness Development Group shares are owned by institutional investors. Comparatively, 24.4% of Cyanotech shares are owned by institutional investors. 15.6% of Happiness Development Group shares are owned by company insiders. Comparatively, 29.1% of Cyanotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cyanotech has lower revenue, but higher earnings than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Happiness Development Group$95.59M0.07-$49.19M$0.481.90
Cyanotech$23.07M0.14-$5.27M-$0.66-0.70

In the previous week, Happiness Development Group had 1 more articles in the media than Cyanotech. MarketBeat recorded 1 mentions for Happiness Development Group and 0 mentions for Cyanotech. Happiness Development Group's average media sentiment score of 1.66 beat Cyanotech's score of 0.00 indicating that Happiness Development Group is being referred to more favorably in the media.

Company Overall Sentiment
Happiness Development Group Very Positive
Cyanotech Neutral

Summary

Happiness Development Group beats Cyanotech on 9 of the 13 factors compared between the two stocks.

Get Cyanotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYAN vs. The Competition

MetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$3.29M$4.20B$5.62B$9.10B
Dividend YieldN/AN/A5.24%4.00%
P/E Ratio-0.709.3128.1320.27
Price / Sales0.1432.66428.6398.72
Price / CashN/A5.6237.4658.16
Price / Book0.351.328.045.49
Net Income-$5.27M$26.37M$3.18B$250.45M

Cyanotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYAN
Cyanotech
N/A$0.46
flat
N/A+41.1%$3.29M$23.07M-0.7095Gap Down
HAPP
Happiness Development Group
N/A$0.84
flat
N/A-3.3%$5.84M$95.59M1.75215News Coverage
BON
Bon Natural Life
N/A$1.25
flat
N/A-97.4%$209K$23.84M0.00100News Coverage
SMFL
Smart for Life
N/A$0.01
-17.1%
N/A-100.0%$89K$11.11M0.00110Gap Down
CDXC
ChromaDex
3.1362 of 5 stars
N/A$9.03
+∞
N/A$611.50M$99.60M787.29120
BGXX
Bright Green
N/AN/AN/AN/A$11.47MN/A-1.002Gap Down
CYCN
Cyclerion Therapeutics
2.0247 of 5 stars
$2.96
+1.7%
N/A+7.7%$9.47M$2M-2.5430Positive News
TLPH
Talphera
2.0115 of 5 stars
$0.46
0.0%
$5.00
+987.0%
-42.3%$9.43M$650K-1.0219Positive News
DWTX
Dogwood Therapeutics
1.6973 of 5 stars
$4.94
+3.5%
$10.00
+102.6%
N/A$9.43MN/A-0.275
APRE
Aprea Therapeutics
2.9349 of 5 stars
$1.70
+0.3%
$15.50
+814.5%
-56.9%$9.37M$1.50M-0.727
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+24.7%$9.37M$3.03M-0.9920High Trading Volume

Related Companies and Tools


This page (NASDAQ:CYAN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners